Table 1 Clinical characteristics of Kawasaki disease
Patient without CAL (n = 238) | Patient with CAL (n = 127) | p value | |
|---|---|---|---|
Age (year) | 1.5(0.8–2.6) | 1.4(0.7–2.4) | p = 0.316 |
Gender (Male) | 128(53.8%) | 92(72.4%) | p = 0.001* |
IVIG resistance (+) | 15(6.3%) | 29(22.8%) | p < 0.001* |
Clinical features | |||
Oral changes | 230(96.6%) | 125(98.4%) | p = 0.504 |
Conjunctival injection | 230(96.6%) | 124(97.6%) | p = 0.754 |
Extremity changes | 233(97.9%) | 125(98.4%) | p = 1.000 |
Rash | 230(96.6%) | 122(96.1%) | p = 0.773 |
Lymphadenopathy | 28(11.8%) | 15(11.8%) | p = 1.000 |
BCG injection | 130(54.6%) | 58(45.7%) | p = 0.124 |